ADAR and nasopharyngeal carcinoma: The study indicates that the ADAR1-miR-142-3p axis is crucial in the progression of NPC and its strategies for immune evasion, thus underscoring miR-142-3p as a potential prognostic biomarker and therapeutic target in NPC (220).